全文获取类型
收费全文 | 69271篇 |
免费 | 6307篇 |
国内免费 | 5062篇 |
专业分类
耳鼻咽喉 | 401篇 |
儿科学 | 719篇 |
妇产科学 | 877篇 |
基础医学 | 8714篇 |
口腔科学 | 1186篇 |
临床医学 | 9282篇 |
内科学 | 10553篇 |
皮肤病学 | 768篇 |
神经病学 | 3649篇 |
特种医学 | 2413篇 |
外国民族医学 | 41篇 |
外科学 | 7079篇 |
综合类 | 11963篇 |
现状与发展 | 17篇 |
一般理论 | 2篇 |
预防医学 | 4271篇 |
眼科学 | 1824篇 |
药学 | 7364篇 |
74篇 | |
中国医学 | 3663篇 |
肿瘤学 | 5780篇 |
出版年
2024年 | 223篇 |
2023年 | 1199篇 |
2022年 | 2861篇 |
2021年 | 3579篇 |
2020年 | 2601篇 |
2019年 | 2361篇 |
2018年 | 2389篇 |
2017年 | 2047篇 |
2016年 | 2056篇 |
2015年 | 3137篇 |
2014年 | 3938篇 |
2013年 | 3269篇 |
2012年 | 4797篇 |
2011年 | 5668篇 |
2010年 | 3275篇 |
2009年 | 2482篇 |
2008年 | 3434篇 |
2007年 | 3520篇 |
2006年 | 3610篇 |
2005年 | 3449篇 |
2004年 | 2233篇 |
2003年 | 2196篇 |
2002年 | 1831篇 |
2001年 | 1686篇 |
2000年 | 1768篇 |
1999年 | 1965篇 |
1998年 | 1251篇 |
1997年 | 1342篇 |
1996年 | 1007篇 |
1995年 | 888篇 |
1994年 | 769篇 |
1993年 | 489篇 |
1992年 | 602篇 |
1991年 | 520篇 |
1990年 | 446篇 |
1989年 | 393篇 |
1988年 | 324篇 |
1987年 | 283篇 |
1986年 | 249篇 |
1985年 | 173篇 |
1984年 | 102篇 |
1983年 | 71篇 |
1982年 | 38篇 |
1981年 | 52篇 |
1980年 | 28篇 |
1979年 | 38篇 |
1963年 | 1篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
91.
Lensectomy and vitrectomy. Analysis of 320 cases 总被引:5,自引:1,他引:4
92.
Neuroprotective activity with magnesium associated with animal models of cerebral ischaemia, seizure, perinatal hypoxia/ischaemia, subarachnoid haemorrhage and traumatic brain injury has provided the justification for clinical stroke trials. However, the recent IMAGES stroke clinical trial found magnesium to be largely ineffective. Hence, due to the negative stroke trial outcome, current FAST-MAG trial and our own experience with magnesium in cerebral ischaemia animal models, we thought it prudent to review these preclinical and clinical studies. We reviewed nine studies describing the use of magnesium following global cerebral ischaemia and fourteen following focal cerebral ischaemia. Four global ischaemia and six focal ischaemia studies did not show a significant neuroprotective effect with magnesium. In the majority of positive magnesium studies animal body temperature was not monitored post-ischaemia. Thus the effects of post-ischaemic hypothermia cannot be ruled out as a confounding factor in positive magnesium cerebral ischaemia studies. Moreover, data from our own laboratory indicates that magnesium is only neuroprotective when combined with post-ischaemic hypothermia. These data provide a possible explanation of why the IMAGES trial was largely unsuccessful, as current stroke patient management does not involve hypothermia induction. Future preclinical and clinical cerebral ischaemia trials with magnesium should consider combining treatment with mild hypothermia. 相似文献
93.
Yanke Yu Wen Zhu Huiling Diao Chunxian Zhou Fanqing F Chen Jun Yang 《Toxicology in vitro》2006,20(6):959-965
Comet assay is a useful technique in the detection of DNA damages, particularly DNA strand breaks; and it has been utilized to show that a potent carcinogen N-methyl-N'-nitro-N-nitrosoguanidine (MNNG), can induce such damages. Recently, gammaH2AX foci formation has been suggested as another sensitive way to detect DNA double strand breaks (DSBs). However, there is no systematic comparison being conducted to evaluate the consistency of these two methods. Using MNNG as a model chemical, the sensitivity of neutral comet assay and gammaH2AX foci formation in detecting MNNG-induced damage was studied. It was found that at concentrations of 0.1 and 1 microg/ml, both methods can detect MNNG-induced damage in human amnion FL cells. However, at 0.1 microg/ml, comet assay revealed more percentage of cells with DNA damage than gammaH2AX fluorescence revealed. On the other hand, while gammaH2AX foci were readily formed at very early times by 10 microg/ml MNNG treatment, neutral comet assay did not detect any significant DNA damage at the same time points. In addition, 10 microg/ml MNNG induced a distinct whole nuclei staining pattern of gammaH2AX, a type of DNA damage which was not detected by neutral comet assay but could be detected by alkaline comet assay. Therefore, gammaH2AX may be used as a sensitive indicator for DNA damage. 相似文献
94.
微波干燥法对腊叶标本压制的实验研究 总被引:2,自引:1,他引:1
目的:寻求一种不受气候条件影响而能成功制作腊叶标本的新技术。方法:采用微波干燥法,即用微波炉,由创制的直径31cm瓦楞纸板、吸水纸与玻璃皿组成的压制程序进行微波干燥。结果:微波干燥法可用于腊叶标本压制,且优于传统的常规腊叶标本压制方法。结论:本研究为腊叶标本的制作提供了一个新方法,收到了便捷、高效、且保色的理想效果。 相似文献
95.
96.
羟甲芬太尼(I)是一个新的高强度高选择性阿片μ受体激动剂。本文用cis-A-N-[1-(2-羟基-2-苯乙基)-3-甲基-4-哌啶基]-苯胺(II)或cis-N-[1-(苯甲酰甲基)-3-甲基-4-哌啶基]-苯胺(III)作为前体合成了[11C]-羟甲芬太尼,以便用正电子发射断层扫描(PET)来观察μ受体。通过水解cis-A-羟甲芬太尼(I)和cis-N-[1-(苯甲酰甲基)-3-甲基-4-哌啶]-N-苯基丙酰胺(cis-IV)的4-N-丙酰基分别获得II和III。溴乙烷的格氏试剂与回旋加速器产生的[11C]-二氧化碳反应后继而直接加入邻苯二甲酸二酰氯和2,6-二叔丁基吡啶生成同位素标记中间体[11C]-丙酰氯。[11C]-丙酰氯与OH-前体(II)反应后再经HPLC分离纯化直接得[11C]-羟甲芬太尼;[11C]-丙酰氯与酮-前体(III)反应后,再用硼氢化钠甲醇溶液处理,然后进行HPLC分离纯化得[11C]-羟甲芬太尼。两种方法均可获得ll.1~14.8GBq/μmol的特异性放射化学纯[11C]-羟甲芬太尼。总共耗时为40~50min(EOB)。 相似文献
97.
霍奇金淋巴瘤组织中H/RS细胞与其背景细胞的微切割及其IgH基因重排检测 总被引:2,自引:0,他引:2
目的 从基因水平探讨霍奇金淋巴瘤(HL)组织中H/RS细胞(Hodgkin and Reed-Sternberg cells)是否起源于B细胞、H/RS细胞的克隆性以及与背景淋巴细胞的相互关系。方法 对33例经典霍奇金淋巴瘤(cHL)石蜡刮片组织进行IgH基因重排分析,并对其中6例重排阳性的病例经B细胞特异性激活蛋白(BSAP)免疫标记,将标记阳性的H/RS细胞和背景淋巴细胞进行微切割后进一步行IgH基因重排分析。结果 16例石蜡刮片组织IgH基因重排阳性。对6例经BSAP标记的cHL成功进行了微切割,其中19管H/RS细胞中,有14管出现重排阳性,细胞数目不同的各管阳性率无显著性差异(P=0.290);12管背景淋巴细胞有2管出现重排阳性,H/RS细胞与背景淋巴细胞的阳性率有显著性差异(P=0.002)。结论 支持H/RS细胞来源于B细胞的理论,认为部分背景淋巴细胞可能具有瘤性增生活性,参与H/RS细胞的前体细胞组成。 相似文献
98.
长沙市小学生焦虑障碍现状调查 总被引:19,自引:2,他引:17
目的 初步了解小学儿童焦虑障碍的患病现况。方法 使用焦虑性情绪障碍筛查表 (SCARED)调查长沙市某小学 2~ 6年级的 5 6 5名小学生 ,并对量表总分≥划界分 (2 3分 )的学生进行面谈。结果 在 5 6 5名小学生 (男生2 90名 ,女生 2 75名 )中 ,SCARED筛查阳性的有 14 0名 ,占总人数的 2 4 78%。使用中国精神障碍分类与诊断标准 (第三版 ) (CCMD 3)对筛查阳性者进行面谈 ,发现符合焦虑障碍诊断标准的 32例 (男 15 ,女 17) ,患病率为 5 6 6 % ,其中儿童分离性焦虑症 7例 ,患病率为 1 2 4 % ;儿童广泛焦虑症 11例 (1 95 % ) ;儿童恐惧症 10例 (1 77% ) ;儿童社交恐惧症 14例(2 4 8% ) ;有 8例存在 2~ 3种焦虑障碍共病 ;无 1例诊断为学校恐怖症、选择性缄默症和惊恐发作。结论 在儿童中焦虑情绪存在较普遍 ,这对儿童的学习、行为、自我意识造成不良影响 ,应予以积极干预。 相似文献
99.
Cheuk‐Kin Lo Colin S.H. Chu Tong Zhu Chan‐Chung Ma Kai‐Ming Ko Kwok‐Keung Ho 《Surgical Practice》2007,11(4):147-153
Aim: The prognosis of patients with disseminated colorectal carcinoma is poor except for those with single organ pulmonary or hepatic metastases. The objective of the present study was to evaluate the result of pulmonary metastasectomy for colorectal secondary and to identify the prognostic factors. Methods: This was a retrospective study of 80 patients who had pulmonary metastasectomy for pulmonary secondary from colorectal carcinoma in Queen Elizabeth Hospital, Hong Kong. Results: The overall 5‐year and 10‐year survival rates of the entire cohort were 42.5% and 35.5%, respectively. High premetastasectomy carcinoembryonic antigen (> 20 μg/dL), short disease‐free interval (< 12 months) and incomplete resection were the independent prognostic factors. Neither the characteristics of the primary colorectal tumour nor the number of metastatic nodules had a significant contribution to the long‐term survival. Six patients underwent second pulmonary metastasectomy and three were still free from tumour recurrence after the second operation. Conclusion: Patients with pulmonary metastases from colorectal carcinoma would benefit from pulmonary metastasectomy. High premetastasectomy carcinoembryonic antigen and short disease‐free interval were negative predictive factors for survival. Long‐term follow‐up study is required, as recurrence can occur more than 5 years after pulmonary metastasectomy. Also, whether the survival benefit is due to surgical treatment effect or lead‐time bias remains undecided. 相似文献
100.
BACKGROUND: The treatment of diffuse brain injury during an acute period is focused on relieving degrees of secondary brain injury. Generation and development of pathological changes of secondary brain injury depend on signal conduction, so down-regulating over response of astrocyte through interfering a key link of signal conduction pathway may bring a new thinking for the treatment of diffuse brain injury.
OBJECTIVE: To observe the effect of over activity of extracellular signal regulated kinases 1/2 (ERK1/2) signal pathway on the response of astrocyte during an acute period of diffuse brain injury.
DESIGN: Completely randomized grouping and controlled animal study.
SETTINGS: Department of Neurosurgery, the Third Affiliated Hospital, Nanchang University; Department of Neurosurgery, Union Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology.
MATERIALS: A total of 158 healthy male SD rats, of 11 weeks old, weighing 320–370 g, were provided by Experimental Animal Faulty, Tongji Medical College, Huazhong University of Science and Technology. Rabbit-anti-phosphorylated ERK1/2 (pERK1/2) polyclonal antibody was provided by R&D Company; rabbit-anti-glial fibrillary acidic protein (GFAP) polyclonal antibody, SP immunohistochemical kit and horseradish peroxidase (HRP)-labeled goat-anti-rabbit IgG by Santa Cruz Company; specific inhibitor U0126 of ERK1/2 signal pathway by Alexis Company.
METHODS: The experiment was carried out in the Laboratory of Neurosurgery, Union Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology from September 2004 to March 2006. ① Detection of pERK1/2 expression: A total of 110 rats were randomly divided into sham operation group (n =5), model group (n =35), high-dosage U0126 group (n =35) and low-dosage U0126 group (n =35). Rats in the sham operation group were only treated with incision of epicranium and fixation of backup plate, but not hit. Rats in the model group were used to establish diffuse brain injury models based on Marmarou free falling body without drug intervention. Rats in the high- and low-dosage U0126 groups were injected into caudal vein with 0.1 and 0.05 mg/kg U0126, respectively, and then, rats were hit to establish injured models. Every 5 rats were collected from model, high- and low-dosage U0126 groups at 5, 30 minutes, 3, 12, 24, 72 hours and 7 days after diffuse brain injury to detect pERK1/2 expression in cortex of parietal lobe based on Western blot technique. ② Distribution of pERK1/2 and positive GFAP cells in brain tissue: Another 48 rats were randomly divided into sham operation group (n =3), model group (n =15), high-dosage U0126 group (n =15) and low-dosage U0126 group (n =15). The intervention and administration were dealt as the same as those mentioned above. Every 3 rats were collected from model, high- and low-dosage U0126 groups at 30 minutes, 3, 12, 24 and 72 hours after model establishment to observe the distribution of pERK1/2 and postive GFAP cells in brain tissue which was cut from coronal section at Bregma –4.8 mm layer with immunohistochemical staining.
MAIN OUTCOME MEASURES: pERK1/2 expression in cortex of parietal lobe and distribution of pERK1/2 and positive GFAP cells in brain tissues.
RESULTS: ① pERK1/2 expression: After diffuse brain injury, pERK1/2 expression in cortex of parietal lobe was rapidly increased in the model group, reached at peak at 5 minutes and then decreased gradually. But the expression was still in a high level until the 72nd hour and fallen to the basic level on the 7th day. pERK1/2 level was lower in high- and low-dosage U0126 groups than that in model group at various time points (P < 0.01); meanwhile, pERK1/2 level was lower in high-dosage U0126 group than that in low-dosage U0126 group. The results showed that there was a certain dosage dependence on pERK1/2 expression. ② Distribution of pERK1/2 and positive GFAP cells in brain tissue: Positive expression of pERK1/2 lasted in brain tissue from 30 minutes to 72 hours after diffuse brain injury (P < 0.05). In addition, from 30 minutes to 3 hours, brown-yellow stained cells were mainly distributed in plasma, but rarely in nucleus. A lot of positive cells had tree-like apophysis, which was similar to neurons. With the time passing by, more and more nuclei manifested positive stains; moreover, nuclei mainly manifested positive staining until 24 hours after diffuse brain injury. Immune-positive pERK1/2 cells were widely distributed in brain tissue, especially mainly in binding site between deep cortex and cerebral white matter, and then in hippocampus. In addition, ependymal cell and vascular endothelial cells of choroids plexus also manifested strongly positive staining. As compared with model group, positive cells were decreased gradually in high- and low-dosage U0126 groups. However, number of positive cells was less in high-dosage U0126 group than that in low-dosage U0126 group.
CONCLUSION: Diffuse brain injury strongly induces the activity of ERK1/2 signal pathway and response of astrocyte; in addition, U0126 can inhibit response of glial cells during an acute period, and the effect manifests dosage dependence. 相似文献